Form SCHEDULE 13D/A Mersana Therapeutics, Filed by: Bain Capital Life Sciences Fund II, L.P. Jan 8, 2026 04:30PM
Form SCHEDULE 13D/A Mersana Therapeutics, Filed by: Bain Capital Life Sciences Fund II, L.P. Nov 13, 2025 06:45PM
Day One Biopharmaceuticals to acquire Mersana Therapeutics for $285M Nov 13, 2025 06:00AM
Day One Biopharmaceuticals to Acquire Mersana Therapeutics Nov 13, 2025 06:00AM
Form SC 13D/A Mersana Therapeutics, Filed by: Bain Capital Life Sciences Fund II, L.P. Nov 15, 2024 04:46PM


May 11, 2022 05:27PM Form SC 13D/A Mersana Therapeutics, Filed by: Bain Capital Life Sciences Fund II, L.P.
Apr 14, 2022 04:56PM Form SC 13D/A Mersana Therapeutics, Filed by: Bain Capital Life Sciences Fund II, L.P.
Feb 8, 2022 05:03PM Form SC 13D/A Mersana Therapeutics, Filed by: Bain Capital Life Sciences Fund II, L.P.
Jan 3, 2022 05:10PM Form SC 13D/A Mersana Therapeutics, Filed by: Bain Capital Life Sciences Fund II, L.P.
Jan 12, 2021 05:20PM Form SC 13D/A Mersana Therapeutics, Filed by: Bain Capital Life Sciences Fund II, L.P.
May 8, 2020 06:00AM Mersana Therapeutics Announces First Quarter 2020 Financial Results and Provides Business Update
Apr 17, 2020 05:26PM Form SC 13D Mersana Therapeutics, Filed by: Bain Capital Life Sciences Fund II, L.P.
Apr 7, 2020 10:07PM Mersana Therapeutics Raises $65 Million in Gross Proceeds Through its At-the-Market Facility